Elevated serum manganese superoxide dismutase in acute leukemias

Area of Science:

• Biochemistry
• Oncology
• Immunology

Background:

• Acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL) are significant hematologic malignancies.
• Manganese-superoxide dismutase (Mn-SOD) is a key antioxidant enzyme.
• Understanding biomarkers for leukemia activity is crucial for patient management.

Purpose of the Study:

• To investigate serum manganese-superoxide dismutase (Mn-SOD) levels in patients with AML and ALL.
• To explore the relationship between serum Mn-SOD levels and disease activity in leukemia.

Main Methods:

• Serum Mn-SOD levels were measured in normal subjects, AML patients, and ALL patients.
• Serum Mn-SOD levels were compared across groups.
• Correlations between serum Mn-SOD, intracellular Mn-SOD, and serum lactate dehydrogenase (LDH) were assessed.
• Changes in serum Mn-SOD levels during leukemia regression were monitored.

Main Results:

• Serum Mn-SOD levels were significantly higher in AML (159.6 +/- 77.1 ng/ml) and ALL (154.4 +/- 77.0 ng/ml) patients compared to normal subjects (94.1 +/- 23.5 ng/ml).
• Serum Mn-SOD levels did not correlate with intracellular Mn-SOD levels.
• Serum Mn-SOD levels showed a strong correlation with serum lactate dehydrogenase (LDH) values.
• A decrease in serum Mn-SOD levels was observed during leukemia regression.

Conclusions:

• Elevated serum Mn-SOD levels are associated with AML and ALL.
• Serum Mn-SOD levels correlate with disease activity and may serve as a useful biomarker for monitoring treatment response in leukemia.